Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects

• Published in: Birth defects research. A Clinical and molecular teratology 2004-03, Vol.70 (3), p.107-113
• Main Authors: Cleves, Mario A., Savell Jr, Van H., Raj, Sarika, Zhao, Weizhi, Correa, Adolfo, Werler, Martha M., Hobbs, Charlotte A.
• Format: Article
• Language: English
• Subjects: acetaminophen; Acetaminophen - adverse effects; Anti-Inflammatory Agents, Non-Steroidal - adverse effects; Biological and medical sciences; Case-Control Studies; congenital heart defects; Drug toxicity and drugs side effects treatment; Female; Heart Septal Defects, Ventricular - chemically induced; Humans; Infant, Newborn; Male; Maternal Exposure - adverse effects; maternal fever; Medical sciences; Miscellaneous (drug allergy, mutagens, teratogens...); National Birth Defects Prevention Study; NSAIDs; Pharmacology. Drug treatments; Pregnancy - drug effects; ventricular septal defects
• ISSN: 1542-0752; 1542-0760
• DOI: 10.1002/bdra.20005

BACKGROUND Muscular ventricular septal defects (mVSDs) are the most common congenital heart defects. Previous studies have suggested maternal use of acetaminophen or nonsteroidal anti‐inflammatory drugs (NSAIDs), and/or fever as risk factors. We evaluated the association between mVSDs and maternal use of acetaminophen or NSAIDs adjusting for fever. METHODS Infants with nonsyndromic mVSDs (cases) and without birth defects (controls), with gestational age ≥37 weeks and their mothers were enrolled in the National Birth Defects Prevention Study. Two exposure periods were defined: the first trimester of pregnancy, and one month before pregnancy through delivery. Mothers reporting fever or medication use at least once during either period were considered exposed. Adjusted odds ratios and 95% confidence intervals were estimated independently for each exposure period. RESULTS The analysis included 168 cases and 692 controls. Two case groups were evaluated: all mVSD infants (n = 168) (including those with associated minor cardiac defects or noncardiac defects), and infants with isolated mVSDs (n = 133). Mothers of cases were less likely to be African‐American than Caucasian (OR, 0.36; 95% CI, 0.18, 0.73). Approximately equal numbers of case mothers and control mothers (10.4 versus 9.7%, respectively) reported at least one febrile episode during the first trimester. Neither acetaminophen nor NSAID exposure was significantly associated with mVSDs. This was true for both case groups and both exposure periods. CONCLUSIONS Significant associations were not detected between the occurrence of mVSDs and maternal use of NSAIDs or acetaminophen adjusting for maternal fever, nor were they detected between maternal fever and mVSDs. Birth Defects Research (Part A), 2004. Published 2004 Wiley‐Liss, Inc.